Science

FDA Approves First Generic Actos to Treat Type 2 Diabetes

Silver Spring, Maryland–(ENEWSPF)–August 17, 2012.  The U.S. Food and Drug Administration today approved the first generic version of Actos (pioglitazone hydrochloride) tablets. Along with diet and exercise, pioglitazone is used to improve blood glucose control in adults with type 2 diabetes. Mylan Pharmaceuticals, based in Morgantown, W.Va., gained FDA approval[Read More…]

MIT-Developed ‘Microthrusters’ Could Propel Small Satellites

 As small as a penny, these thrusters run on jets of ion beams. CAMBRIDGE, Mass.–(ENEWSPF)–August 17, 2012.  A penny-sized rocket thruster may soon power the smallest satellites in space. The device, designed by Paulo Lozano, an associate professor of aeronautics and astronautics at MIT, bears little resemblance to today’s bulky[Read More…]

Victory For Hawai‘i Streams And Communities

Hawaiʻi high court upholds the public trust and Hawaiian rights in Nā Wai ʻEhā Honolulu, HI–(ENEWSPF)–August 16, 2012.  The Hawaiʻi Supreme Court has ordered the state water commission to reconsider the fate of Nā Wai ʻEhā, or “The Four Great Waters” of Waiheʻe River and Waiehu, ʻĪao, and Waikapū Streams[Read More…]

Fact Sheets – New Data on Work-Life Balance

Washington, D.C.–(ENEWSPF)–August 16, 2012.  In response to new data released today by the Bureau of Labor Statistics on the use of paid sick days and workplace flexibility, the Center for American Progress released a series of fact sheets on how conflicts over work-family balance impact the nation’s economy. The series[Read More…]

Ecological Restoration To Begin On Northerly Island

Park District Expands Programs for Campers, At-Risk Youth, as Army Corps of Engineers Begins Work CHICAGO–(ENEWSPF)–August 16, 2012.  Mayor Rahm Emanuel and Park District General Superintendent Michael Kelly announced today that the ecological restoration of Northerly Island Park will begin in the fall as the park becomes a new urban[Read More…]

FDA Recommends X-ray or Other Imaging on Implanted Heart Defibrillators with St. Jude Medical Riata Leads to Help Guide Treatment

Agency orders the company to collect data on the wire insulation function  Silver Spring, Maryland–(ENEWSPF)–August 16, 2012.  The U.S. Food and Drug Administration recommended today that patients who have implantable heart defibrillators with Riata and Riata ST leads, manufactured by St. Jude Medical, should have X-rays or other imaging alternatives[Read More…]

Most read stories this week

Take a Survey

ARCHIVES